Study: Gene editing therapy for early-stage Huntington’s disease may have long-lasting benefits

By | July 8, 2021
In a new study on mice, Johns Hopkins Medicine researchers report that using MRI scans to measure blood volume in the brain can serve as a noninvasive way to potentially track the progress of gene editing therapies for early-stage Huntington’s disease, a neurodegenerative disorder that attacks brain cells.